| Clinicopathological Characteristics | BC Patients | |
| No. | % | |
| Age | 52.23 ± 9.53 | |
| Menopausal Status |
|
|
| Pre-menopausal | 13 | 21.7% |
| Post-menopausal | 47 | 78.3% |
| Family History |
|
|
| Negative | 51 | 85% |
| Positive | 9 | 15% |
| Type of Surgery |
|
|
| Modified Radical Mastectomy | 60 | 100% |
| Tumor Type |
|
|
| Invasive Ductal Carcinoma | 60 | 100% |
| Estrogen Receptor (ERα) Expression |
|
|
| - | 7 | 11.7% |
| + | 20 | 33.3% |
| ++ | 25 | 41.7% |
| +++ | 8 | 13.3% |
| Progesterone Receptor (PR) Expression |
|
|
| - | 10 | 16.7% |
| + | 24 | 40% |
| ++ | 20 | 33.3% |
| +++ | 6 | 10% |
| Her2/neu Expression |
|
|
| - | 35 | 58.4% |
| + | 8 | 13.3% |
| ++ | 8 | 13.3% |
| +++ | 5 | 8.3% |
| Unknown | 4 | 6.7% |
| Tumor size (Cm) |
|
|
| T1 (≤2) | 17 | 28.3% |
| T2 (2 - ≤5) | 37 | 61.7% |
| T3 (>5) | 6 | 10% |
| Lymph Nodes Involvement |
|
|
| N0 | 14 | 23.3% |
| N1 (1 - 3) | 25 | 41.7% |
| N2 (4 - 9) | 3 | 5% |
| N3 (>9) | 18 | 30% |